The gut and oral microbiome in HIV disease

A workshop report

D. L. Moyes, Deepak Saxena, M. D. John, Daniel Malamud

Research output: Contribution to journalArticle

Abstract

Recent years have seen a massive expansion in our understanding of how we interact with our microbial colonists. The development of new, rapid sequencing techniques such as pyrosequencing and other next-generation sequencing systems have enabled us to begin to characterise the constituents of our diverse microbial communities, revealing the astonishing genetic richness that is our microbiome. Despite this, our ignorance of how these communities change over the course of an HIV infection is profound. Whilst some steps have been made to characterise the HIV microbiome at selected sites, these reports are still limited and much remains to be done. It has become apparent, however, that host-microbiota interactions are perturbed during HIV infections, with microbial translocation of potential pathogens linked to a variety of different HIV complications, including more rapid progression of disease. The use of probiotics and prebiotics has been investigated as treatments to alleviate symptoms for a variety of conditions, and is now being proposed for the treatment of symptoms associated with HIV. However, this is a new area of investigations and many questions remain unanswered. What we know about both of these topics is a drop in the ocean compared with what we need to know. In this article, we report on a workshop where these two major under-investigated research areas were presented, and future directions explored and discussed.

Original languageEnglish (US)
Pages (from-to)166-170
Number of pages5
JournalOral Diseases
Volume22
DOIs
StatePublished - Apr 1 2016

Fingerprint

Microbiota
HIV
Education
HIV Infections
Prebiotics
Probiotics
Disease Progression
Research
Gastrointestinal Microbiome

Keywords

  • HIV transmission
  • HIV/AIDS
  • Infectious disease
  • Microbial translocation
  • Microbiome
  • Microbiota
  • Prebiotics
  • Probiotics

ASJC Scopus subject areas

  • Dentistry(all)
  • Otorhinolaryngology

Cite this

The gut and oral microbiome in HIV disease : A workshop report. / Moyes, D. L.; Saxena, Deepak; John, M. D.; Malamud, Daniel.

In: Oral Diseases, Vol. 22, 01.04.2016, p. 166-170.

Research output: Contribution to journalArticle

@article{48f29a72683a4e5d9f780521606b9247,
title = "The gut and oral microbiome in HIV disease: A workshop report",
abstract = "Recent years have seen a massive expansion in our understanding of how we interact with our microbial colonists. The development of new, rapid sequencing techniques such as pyrosequencing and other next-generation sequencing systems have enabled us to begin to characterise the constituents of our diverse microbial communities, revealing the astonishing genetic richness that is our microbiome. Despite this, our ignorance of how these communities change over the course of an HIV infection is profound. Whilst some steps have been made to characterise the HIV microbiome at selected sites, these reports are still limited and much remains to be done. It has become apparent, however, that host-microbiota interactions are perturbed during HIV infections, with microbial translocation of potential pathogens linked to a variety of different HIV complications, including more rapid progression of disease. The use of probiotics and prebiotics has been investigated as treatments to alleviate symptoms for a variety of conditions, and is now being proposed for the treatment of symptoms associated with HIV. However, this is a new area of investigations and many questions remain unanswered. What we know about both of these topics is a drop in the ocean compared with what we need to know. In this article, we report on a workshop where these two major under-investigated research areas were presented, and future directions explored and discussed.",
keywords = "HIV transmission, HIV/AIDS, Infectious disease, Microbial translocation, Microbiome, Microbiota, Prebiotics, Probiotics",
author = "Moyes, {D. L.} and Deepak Saxena and John, {M. D.} and Daniel Malamud",
year = "2016",
month = "4",
day = "1",
doi = "10.1111/odi.12415",
language = "English (US)",
volume = "22",
pages = "166--170",
journal = "Oral Diseases",
issn = "1354-523X",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The gut and oral microbiome in HIV disease

T2 - A workshop report

AU - Moyes, D. L.

AU - Saxena, Deepak

AU - John, M. D.

AU - Malamud, Daniel

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Recent years have seen a massive expansion in our understanding of how we interact with our microbial colonists. The development of new, rapid sequencing techniques such as pyrosequencing and other next-generation sequencing systems have enabled us to begin to characterise the constituents of our diverse microbial communities, revealing the astonishing genetic richness that is our microbiome. Despite this, our ignorance of how these communities change over the course of an HIV infection is profound. Whilst some steps have been made to characterise the HIV microbiome at selected sites, these reports are still limited and much remains to be done. It has become apparent, however, that host-microbiota interactions are perturbed during HIV infections, with microbial translocation of potential pathogens linked to a variety of different HIV complications, including more rapid progression of disease. The use of probiotics and prebiotics has been investigated as treatments to alleviate symptoms for a variety of conditions, and is now being proposed for the treatment of symptoms associated with HIV. However, this is a new area of investigations and many questions remain unanswered. What we know about both of these topics is a drop in the ocean compared with what we need to know. In this article, we report on a workshop where these two major under-investigated research areas were presented, and future directions explored and discussed.

AB - Recent years have seen a massive expansion in our understanding of how we interact with our microbial colonists. The development of new, rapid sequencing techniques such as pyrosequencing and other next-generation sequencing systems have enabled us to begin to characterise the constituents of our diverse microbial communities, revealing the astonishing genetic richness that is our microbiome. Despite this, our ignorance of how these communities change over the course of an HIV infection is profound. Whilst some steps have been made to characterise the HIV microbiome at selected sites, these reports are still limited and much remains to be done. It has become apparent, however, that host-microbiota interactions are perturbed during HIV infections, with microbial translocation of potential pathogens linked to a variety of different HIV complications, including more rapid progression of disease. The use of probiotics and prebiotics has been investigated as treatments to alleviate symptoms for a variety of conditions, and is now being proposed for the treatment of symptoms associated with HIV. However, this is a new area of investigations and many questions remain unanswered. What we know about both of these topics is a drop in the ocean compared with what we need to know. In this article, we report on a workshop where these two major under-investigated research areas were presented, and future directions explored and discussed.

KW - HIV transmission

KW - HIV/AIDS

KW - Infectious disease

KW - Microbial translocation

KW - Microbiome

KW - Microbiota

KW - Prebiotics

KW - Probiotics

UR - http://www.scopus.com/inward/record.url?scp=84964389737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964389737&partnerID=8YFLogxK

U2 - 10.1111/odi.12415

DO - 10.1111/odi.12415

M3 - Article

VL - 22

SP - 166

EP - 170

JO - Oral Diseases

JF - Oral Diseases

SN - 1354-523X

ER -